Sens. Say Pay-For-Delay Legislation Still Needed

Law360, New York (June 19, 2013, 8:08 PM EDT) -- Even though the U.S. Supreme Court finally ruled Monday that pay-for-delay deals can violate antitrust laws, legislators trying to stop the pharmaceutical patent settlements have said in recent days that the decision doesn't go far enough and vowed to press ahead with legislative fixes.

Sens. Amy Klobuchar, D-Minn., Chuck Grassley, R-Iowa, and Al Franken, D-Minn., all applauded the justices' conclusion that the deals — in which branded drug companies pay generics makers to delay market entry as part of patent litigation settlement — may be anti-competitive....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.